This company listing is no longer active
BBS-Bioactive Bone Substitutes Oyj Past Earnings Performance
Past criteria checks 0/6
Key information
-8.1%
Earnings growth rate
4.6%
EPS growth rate
Biotechs Industry Growth | 0.7% |
Revenue growth rate | 105.5% |
Return on equity | -72.4% |
Net Margin | -4,815.5% |
Next Earnings Update | 25 Aug 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How BBS-Bioactive Bone Substitutes Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 22 | 0 | -3 | 1 | 0 |
30 Sep 22 | 0 | -3 | 1 | 0 |
30 Jun 22 | 0 | -3 | 1 | 0 |
31 Mar 22 | 0 | -3 | 1 | 0 |
31 Dec 21 | 0 | -3 | 1 | 0 |
30 Sep 21 | 0 | -3 | 1 | 0 |
30 Jun 21 | 0 | -3 | 1 | 0 |
31 Mar 21 | 0 | -3 | 1 | 0 |
31 Dec 20 | 0 | -3 | 1 | 0 |
30 Sep 20 | 0 | -2 | 1 | 0 |
30 Jun 20 | 0 | -2 | 1 | 0 |
31 Mar 20 | 0 | -2 | 1 | 0 |
31 Dec 19 | 0 | -2 | 1 | 0 |
30 Sep 19 | 0 | -2 | 1 | 0 |
30 Jun 19 | 0 | -2 | 1 | 0 |
31 Mar 19 | 0 | -1 | 1 | 0 |
31 Dec 18 | 0 | 0 | 1 | 0 |
30 Sep 18 | 0 | -1 | 1 | 0 |
30 Jun 18 | 0 | -3 | 1 | 0 |
31 Mar 18 | 0 | -4 | 1 | 0 |
31 Dec 17 | 0 | -4 | 1 | 0 |
Quality Earnings: BONES is currently unprofitable.
Growing Profit Margin: BONES is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BONES is unprofitable, and losses have increased over the past 5 years at a rate of 8.1% per year.
Accelerating Growth: Unable to compare BONES's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BONES is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15.9%).
Return on Equity
High ROE: BONES has a negative Return on Equity (-72.4%), as it is currently unprofitable.